SIMILAR PATTERNS OF AMINO ACIDS FOR 4XE0_A_40LA1101
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1amy | 1,4-ALPHA-D-GLUCANGLUCANOHYDROLASE (Hordeum vulgare) |
PF00128(Alpha-amylase)PF07821(Alpha-amyl_C2) | 5 | PRO A 318ILE A 311VAL A 304ASP A 323ILE A 334 | None | 1.26A | 4xe0A-1amyA:2.2 | 4xe0A-1amyA:17.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1cja | PROTEIN(ACTIN-FRAGMINKINASE) (Physarumpolycephalum) |
PF09192(Act-Frag_cataly) | 5 | THR A 169ASN A 171MET A 220ILE A 231ASP A 232 | AMP A 425 ( 4.3A)NoneAMP A 425 ( 4.0A)AMP A 425 (-4.4A)AMP A 425 (-2.7A) | 1.47A | 4xe0A-1cjaA:6.9 | 4xe0A-1cjaA:18.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1fp2 | ISOFLAVONEO-METHYLTRANSFERASE (Medicago sativa) |
PF00891(Methyltransf_2)PF08100(Dimerisation) | 5 | ILE A 255VAL A 250THR A 202ASN A 176ASP A 219 | SAH A1699 (-4.9A)NoneNoneNoneSAH A1699 (-2.9A) | 1.46A | 4xe0A-1fp2A:undetectable | 4xe0A-1fp2A:16.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1fts | FTSY (Escherichiacoli) |
PF00448(SRP54)PF02881(SRP54_N) | 5 | ILE A 368VAL A 363ASP A 382THR A 383ILE A 400 | None | 1.31A | 4xe0A-1ftsA:undetectable | 4xe0A-1ftsA:16.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1jxk | ALPHA-AMYLASE,SALIVARY (Homo sapiens) |
PF00128(Alpha-amylase)PF02806(Alpha-amylase_C) | 5 | ILE A 196VAL A 98ASP A 167ASN A 137ILE A 179 | NoneNone CA A 492 (-2.3A)NoneNone | 1.31A | 4xe0A-1jxkA:undetectable | 4xe0A-1jxkA:18.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1o6u | SEC14-LIKE PROTEIN 2 (Homo sapiens) |
PF00650(CRAL_TRIO) | 5 | ILE A 258VAL A 237ASP A 92THR A 150ILE A 152 | None | 1.44A | 4xe0A-1o6uA:undetectable | 4xe0A-1o6uA:18.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1o6u | SEC14-LIKE PROTEIN 2 (Homo sapiens) |
PF00650(CRAL_TRIO) | 5 | TYR A 241VAL A 237ASP A 92THR A 150ILE A 152 | None | 1.40A | 4xe0A-1o6uA:undetectable | 4xe0A-1o6uA:18.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ofe | FERREDOXIN-DEPENDENTGLUTAMATE SYNTHASE 2 (Synechocystissp. PCC 6803) |
PF00310(GATase_2)PF01493(GXGXG)PF01645(Glu_synthase)PF04898(Glu_syn_central) | 5 | PRO A 604VAL A 584ASP A 578ASN A 574ILE A 616 | None | 1.14A | 4xe0A-1ofeA:undetectable | 4xe0A-1ofeA:22.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ose | PORCINEALPHA-AMYLASE (Sus scrofa) |
PF00128(Alpha-amylase)PF02806(Alpha-amylase_C) | 5 | ILE A 196VAL A 98ASP A 167ASN A 137ILE A 179 | NoneNone CA A 500 ( 2.2A)NoneNone | 1.36A | 4xe0A-1oseA:undetectable | 4xe0A-1oseA:18.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1p2f | RESPONSE REGULATOR (Thermotogamaritima) |
PF00072(Response_reg)PF00486(Trans_reg_C) | 5 | ILE A 106VAL A 18ASP A 50ILE A 75ASP A 96 | None | 1.33A | 4xe0A-1p2fA:undetectable | 4xe0A-1p2fA:12.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1q1n | HYPOTHETICALZINC-TYPE ALCOHOLDEHYDROGENASE-LIKEPROTEIN IN PRE5-FET4INTERGENIC REGION (Saccharomycescerevisiae) |
PF00107(ADH_zinc_N)PF08240(ADH_N) | 5 | VAL A 186ASP A 258ASN A 260MET A 262ILE A 272 | None | 1.20A | 4xe0A-1q1nA:undetectable | 4xe0A-1q1nA:15.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1zjr | TRNA(GUANOSINE-2'-O-)-METHYLTRANSFERASE (Aquifexaeolicus) |
PF00588(SpoU_methylase)PF12105(SpoU_methylas_C) | 5 | ILE A 80VAL A 28ASP A 31ASN A 32ILE A 42 | None | 1.11A | 4xe0A-1zjrA:undetectable | 4xe0A-1zjrA:12.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2qps | ALPHA-AMYLASE TYPE AISOZYME (Hordeum vulgare) |
PF00128(Alpha-amylase)PF07821(Alpha-amyl_C2) | 5 | PRO A 320ILE A 313VAL A 306ASP A 325ILE A 336 | None | 1.35A | 4xe0A-2qpsA:undetectable | 4xe0A-2qpsA:16.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2v5d | O-GLCNACASE NAGJ (Clostridiumperfringens) |
PF00754(F5_F8_type_C)PF02838(Glyco_hydro_20b)PF07555(NAGidase) | 5 | ILE A 726TYR A 687VAL A 763ASP A 650THR A 655 | NoneNoneNoneNone CA A1770 (-3.8A) | 1.29A | 4xe0A-2v5dA:2.0 | 4xe0A-2v5dA:22.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2x6k | PHOSPHOTIDYLINOSITOL3 KINASE 59F (Drosophilamelanogaster) |
PF00454(PI3_PI4_kinase)PF00613(PI3Ka) | 6 | PRO A 679ILE A 696TYR A 732VAL A 747THR A 751ILE A 822 | NoneNoneX6K A1951 ( 4.3A)X6K A1951 (-4.1A)NoneX6K A1951 (-4.1A) | 0.56A | 4xe0A-2x6kA:28.5 | 4xe0A-2x6kA:26.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2y3a | PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE3-KINASE CATALYTICSUBUNIT BETA ISOFORM (Mus musculus) |
PF00454(PI3_PI4_kinase)PF00613(PI3Ka)PF00792(PI3K_C2)PF00794(PI3K_rbd)PF02192(PI3K_p85B) | 5 | ILE A 845VAL A 848THR A 853MET A 920ILE A 930 | GD9 A2058 (-3.8A)GD9 A2058 (-3.8A)GD9 A2058 ( 4.8A)GD9 A2058 (-3.6A)GD9 A2058 (-4.2A) | 1.01A | 4xe0A-2y3aA:38.7 | 4xe0A-2y3aA:51.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2y3a | PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE3-KINASE CATALYTICSUBUNIT BETA ISOFORM (Mus musculus) |
PF00454(PI3_PI4_kinase)PF00613(PI3Ka)PF00792(PI3K_C2)PF00794(PI3K_rbd)PF02192(PI3K_p85B) | 6 | MET A 773PRO A 779TYR A 833ASP A 856MET A 920ILE A 930 | GD9 A2058 (-4.3A)NoneGD9 A2058 (-3.8A)GD9 A2058 ( 4.6A)GD9 A2058 (-3.6A)GD9 A2058 (-4.2A) | 1.46A | 4xe0A-2y3aA:38.7 | 4xe0A-2y3aA:51.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2y3a | PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE3-KINASE CATALYTICSUBUNIT BETA ISOFORM (Mus musculus) |
PF00454(PI3_PI4_kinase)PF00613(PI3Ka)PF00792(PI3K_C2)PF00794(PI3K_rbd)PF02192(PI3K_p85B) | 6 | MET A 773PRO A 779TYR A 833VAL A 848MET A 920ILE A 930 | GD9 A2058 (-4.3A)NoneGD9 A2058 (-3.8A)GD9 A2058 (-3.8A)GD9 A2058 (-3.6A)GD9 A2058 (-4.2A) | 0.99A | 4xe0A-2y3aA:38.7 | 4xe0A-2y3aA:51.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2y3a | PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE3-KINASE CATALYTICSUBUNIT BETA ISOFORM (Mus musculus) |
PF00454(PI3_PI4_kinase)PF00613(PI3Ka)PF00792(PI3K_C2)PF00794(PI3K_rbd)PF02192(PI3K_p85B) | 7 | PRO A 779ILE A 797TYR A 833ASP A 856THR A 853MET A 920ILE A 930 | NoneNoneGD9 A2058 (-3.8A)GD9 A2058 ( 4.6A)GD9 A2058 ( 4.8A)GD9 A2058 (-3.6A)GD9 A2058 (-4.2A) | 1.25A | 4xe0A-2y3aA:38.7 | 4xe0A-2y3aA:51.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2y3a | PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE3-KINASE CATALYTICSUBUNIT BETA ISOFORM (Mus musculus) |
PF00454(PI3_PI4_kinase)PF00613(PI3Ka)PF00792(PI3K_C2)PF00794(PI3K_rbd)PF02192(PI3K_p85B) | 7 | PRO A 779ILE A 797TYR A 833VAL A 848THR A 853MET A 920ILE A 930 | NoneNoneGD9 A2058 (-3.8A)GD9 A2058 (-3.8A)GD9 A2058 ( 4.8A)GD9 A2058 (-3.6A)GD9 A2058 (-4.2A) | 0.66A | 4xe0A-2y3aA:38.7 | 4xe0A-2y3aA:51.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2yvu | PROBABLEADENYLYL-SULFATEKINASE (Aeropyrumpernix) |
PF01583(APS_kinase) | 5 | PRO A 113ILE A 14TYR A 42VAL A 44ILE A 10 | None | 1.48A | 4xe0A-2yvuA:undetectable | 4xe0A-2yvuA:12.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3a9g | PUTATIVEUNCHARACTERIZEDPROTEIN (Pyrobaculumaerophilum) |
PF07995(GSDH) | 5 | ILE A 38VAL A 41ASP A 360THR A 346ASN A 348 | None | 1.46A | 4xe0A-3a9gA:undetectable | 4xe0A-3a9gA:16.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3c9f | 5'-NUCLEOTIDASE (Candidaalbicans) |
PF00149(Metallophos) | 5 | ILE A 220ASP A 485THR A 476ILE A 252ASP A 449 | None | 1.44A | 4xe0A-3c9fA:undetectable | 4xe0A-3c9fA:20.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3crw | XPD/RAD3 RELATED DNAHELICASE (Sulfolobusacidocaldarius) |
PF06733(DEAD_2)PF13307(Helicase_C_2) | 5 | MET 1 331PRO 1 326TYR 1 156ASN 1 312ILE 1 179 | None | 1.21A | 4xe0A-3crw1:undetectable | 4xe0A-3crw1:20.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3crw | XPD/RAD3 RELATED DNAHELICASE (Sulfolobusacidocaldarius) |
PF06733(DEAD_2)PF13307(Helicase_C_2) | 5 | MET 1 331TYR 1 156VAL 1 188ASN 1 312ILE 1 179 | None | 1.42A | 4xe0A-3crw1:undetectable | 4xe0A-3crw1:20.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ctm | CARBONYL REDUCTASE (Candidaparapsilosis) |
PF13561(adh_short_C2) | 5 | ILE A 272TYR A 254VAL A 251THR A 221ILE A 46 | None | 1.44A | 4xe0A-3ctmA:undetectable | 4xe0A-3ctmA:15.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ec1 | YQEH GTPASE (Geobacillusstearothermophilus) |
PF01926(MMR_HSR1) | 5 | ILE A 101VAL A 165ASP A 218THR A 219ILE A 68 | None | 1.34A | 4xe0A-3ec1A:undetectable | 4xe0A-3ec1A:16.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3eh0 | UDP-3-O-[3-HYDROXYMYRISTOYL] GLUCOSAMINEN-ACYLTRANSFERASE (Escherichiacoli) |
PF00132(Hexapep)PF04613(LpxD)PF14602(Hexapep_2) | 5 | PRO A 96VAL A 207ASP A 232ASN A 233ILE A 172 | None | 1.36A | 4xe0A-3eh0A:undetectable | 4xe0A-3eh0A:14.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3g05 | TRNA URIDINE5-CARBOXYMETHYLAMINOMETHYL MODIFICATIONENZYME MNMG (Escherichiacoli) |
PF01134(GIDA)PF13932(GIDA_assoc) | 5 | PRO A 309VAL A 320THR A 251ASN A 248ILE A 280 | None | 1.50A | 4xe0A-3g05A:undetectable | 4xe0A-3g05A:19.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3jbz | SERINE/THREONINE-PROTEIN KINASE MTOR (Homo sapiens) |
PF00454(PI3_PI4_kinase)PF02259(FAT)PF02260(FATC)PF08771(FRB_dom) | 5 | ILE A2237VAL A2240THR A2245MET A2345ILE A2356 | ADP A2601 (-4.8A)ADP A2601 (-4.1A)ADP A2601 (-4.1A)ADP A2601 ( 4.1A)ADP A2601 (-4.0A) | 1.07A | 4xe0A-3jbzA:19.9 | 4xe0A-3jbzA:22.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3jbz | SERINE/THREONINE-PROTEIN KINASE MTOR (Homo sapiens) |
PF00454(PI3_PI4_kinase)PF02259(FAT)PF02260(FATC)PF08771(FRB_dom) | 6 | PRO A2169TYR A2225VAL A2240ASP A2244MET A2345ILE A2356 | NoneADP A2601 ( 3.8A)ADP A2601 (-4.1A)NoneADP A2601 ( 4.1A)ADP A2601 (-4.0A) | 0.90A | 4xe0A-3jbzA:19.9 | 4xe0A-3jbzA:22.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3jbz | SERINE/THREONINE-PROTEIN KINASE MTOR (Homo sapiens) |
PF00454(PI3_PI4_kinase)PF02259(FAT)PF02260(FATC)PF08771(FRB_dom) | 6 | PRO A2169TYR A2225VAL A2240THR A2245MET A2345ILE A2356 | NoneADP A2601 ( 3.8A)ADP A2601 (-4.1A)ADP A2601 (-4.1A)ADP A2601 ( 4.1A)ADP A2601 (-4.0A) | 0.54A | 4xe0A-3jbzA:19.9 | 4xe0A-3jbzA:22.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3lft | UNCHARACTERIZEDPROTEIN (Streptococcuspneumoniae) |
PF04392(ABC_sub_bind) | 5 | VAL A 228THR A 221ASN A 222ILE A 246ASP A 243 | None | 1.47A | 4xe0A-3lftA:undetectable | 4xe0A-3lftA:15.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3lzx | FERREDOXIN--NADPREDUCTASE 2 (Bacillussubtilis) |
PF07992(Pyr_redox_2) | 5 | PRO A 212ILE A 183VAL A 180ASP A 241ASN A 141 | None | 1.28A | 4xe0A-3lzxA:undetectable | 4xe0A-3lzxA:16.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3men | ACETYLPOLYAMINEAMINOHYDROLASE (Burkholderiapseudomallei) |
PF00850(Hist_deacetyl) | 5 | ILE A 174TYR A 127ASP A 63THR A 64ILE A 55 | None | 1.41A | 4xe0A-3menA:undetectable | 4xe0A-3menA:17.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3my7 | ALCOHOLDEHYDROGENASE/ACETALDEHYDE DEHYDROGENASE (Vibrioparahaemolyticus) |
PF00171(Aldedh) | 5 | PRO A 218ILE A 253VAL A 255THR A 374ASN A 398 | None | 1.49A | 4xe0A-3my7A:undetectable | 4xe0A-3my7A:18.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3nzu | PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE3-KINASE CATALYTICSUBUNIT GAMMAISOFORM (Homo sapiens) |
PF00454(PI3_PI4_kinase)PF00613(PI3Ka)PF00792(PI3K_C2)PF00794(PI3K_rbd) | 5 | ILE A 879VAL A 882THR A 887MET A 953ILE A 963 | NZU A 1 (-4.2A)NZU A 1 (-3.9A)NZU A 1 (-3.8A)NZU A 1 (-3.5A)NZU A 1 (-3.7A) | 0.98A | 4xe0A-3nzuA:33.3 | 4xe0A-3nzuA:35.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3nzu | PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE3-KINASE CATALYTICSUBUNIT GAMMAISOFORM (Homo sapiens) |
PF00454(PI3_PI4_kinase)PF00613(PI3Ka)PF00792(PI3K_C2)PF00794(PI3K_rbd) | 6 | MET A 804PRO A 810TYR A 867VAL A 882MET A 953ILE A 963 | NZU A 1 (-4.7A)NoneNZU A 1 (-3.5A)NZU A 1 (-3.9A)NZU A 1 (-3.5A)NZU A 1 (-3.7A) | 1.29A | 4xe0A-3nzuA:33.3 | 4xe0A-3nzuA:35.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3nzu | PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE3-KINASE CATALYTICSUBUNIT GAMMAISOFORM (Homo sapiens) |
PF00454(PI3_PI4_kinase)PF00613(PI3Ka)PF00792(PI3K_C2)PF00794(PI3K_rbd) | 5 | PRO A 810ILE A 831THR A 887ILE A 963ASP A 964 | NoneNZU A 1 (-4.9A)NZU A 1 (-3.8A)NZU A 1 (-3.7A)NZU A 1 (-4.1A) | 0.87A | 4xe0A-3nzuA:33.3 | 4xe0A-3nzuA:35.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3nzu | PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE3-KINASE CATALYTICSUBUNIT GAMMAISOFORM (Homo sapiens) |
PF00454(PI3_PI4_kinase)PF00613(PI3Ka)PF00792(PI3K_C2)PF00794(PI3K_rbd) | 8 | PRO A 810TRP A 812ILE A 831TYR A 867VAL A 882THR A 887MET A 953ILE A 963 | NoneNoneNZU A 1 (-4.9A)NZU A 1 (-3.5A)NZU A 1 (-3.9A)NZU A 1 (-3.8A)NZU A 1 (-3.5A)NZU A 1 (-3.7A) | 0.46A | 4xe0A-3nzuA:33.3 | 4xe0A-3nzuA:35.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ouu | BIOTIN CARBOXYLASE (Campylobacterjejuni) |
PF00289(Biotin_carb_N)PF02785(Biotin_carb_C)PF02786(CPSase_L_D2) | 5 | ILE A 132VAL A 279ASP A 436THR A 437ASN A 438 | ANP A 460 (-4.2A)NoneNoneANP A 460 (-3.5A)None | 1.06A | 4xe0A-3ouuA:undetectable | 4xe0A-3ouuA:18.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3pb0 | DIHYDRODIPICOLINATESYNTHASE (Thermotogamaritima) |
PF00701(DHDPS) | 5 | ILE A 265TYR A 23THR A 44ASN A 251ILE A 9 | None | 1.47A | 4xe0A-3pb0A:undetectable | 4xe0A-3pb0A:15.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3pb0 | DIHYDRODIPICOLINATESYNTHASE (Thermotogamaritima) |
PF00701(DHDPS) | 5 | PRO A 214TYR A 23THR A 44ASN A 251ILE A 9 | None | 1.39A | 4xe0A-3pb0A:undetectable | 4xe0A-3pb0A:15.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3pnn | CONSERVED DOMAINPROTEIN (Porphyromonasgingivalis) |
no annotation | 5 | ILE A 52VAL A 7ASP A 121MET A 33ILE A 64 | NoneNoneGOL A 301 ( 2.8A)NoneNone | 1.28A | 4xe0A-3pnnA:undetectable | 4xe0A-3pnnA:14.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3td9 | BRANCHED CHAIN AMINOACID ABCTRANSPORTER,PERIPLASMIC AMINOACID-BINDING PROTEIN (Thermotogamaritima) |
PF13458(Peripla_BP_6) | 5 | PRO A 115ILE A 90VAL A 62ASP A 65THR A 66 | None | 1.15A | 4xe0A-3td9A:undetectable | 4xe0A-3td9A:15.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ul4 | CELLULOSOME-ANCHORING PROTEINCELLULOSOME ENZYME,DOCKERIN TYPE I (Ruminiclostridiumthermocellum;Ruminiclostridiumthermocellum) |
PF00963(Cohesin)PF00404(Dockerin_1) | 5 | PRO A 137TYR A 84ASP B 51THR B 50ASN B 42 | NoneNone CA B 66 (-2.2A)None CA B 66 (-3.0A) | 1.42A | 4xe0A-3ul4A:undetectable | 4xe0A-3ul4A:10.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4bfr | PHOSPHATIDYLINOSITOL4,5-BISPHOSPHATE3-KINASE CATALYTIC SSUBUNIT BETA ISOFORM (Mus musculus) |
PF00454(PI3_PI4_kinase)PF00613(PI3Ka)PF00792(PI3K_C2)PF00794(PI3K_rbd) | 5 | ILE A 845VAL A 848THR A 853MET A 920ILE A 930 | J82 A2000 ( 4.4A)J82 A2000 (-3.8A)NoneJ82 A2000 (-3.6A)J82 A2000 (-3.6A) | 1.08A | 4xe0A-4bfrA:40.7 | 4xe0A-4bfrA:57.19 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4bfr | PHOSPHATIDYLINOSITOL4,5-BISPHOSPHATE3-KINASE CATALYTIC SSUBUNIT BETA ISOFORM (Mus musculus) |
PF00454(PI3_PI4_kinase)PF00613(PI3Ka)PF00792(PI3K_C2)PF00794(PI3K_rbd) | 6 | MET A 773PRO A 779TRP A 781ILE A 797ASP A 856ASP A 931 | J82 A2000 (-3.9A)J82 A2000 (-4.5A)NoneJ82 A2000 (-4.4A)NoneJ82 A2000 (-4.9A) | 1.02A | 4xe0A-4bfrA:40.7 | 4xe0A-4bfrA:57.19 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4bfr | PHOSPHATIDYLINOSITOL4,5-BISPHOSPHATE3-KINASE CATALYTIC SSUBUNIT BETA ISOFORM (Mus musculus) |
PF00454(PI3_PI4_kinase)PF00613(PI3Ka)PF00792(PI3K_C2)PF00794(PI3K_rbd) | 6 | MET A 773PRO A 779TRP A 781ILE A 797ASP A 856ILE A 930 | J82 A2000 (-3.9A)J82 A2000 (-4.5A)NoneJ82 A2000 (-4.4A)NoneJ82 A2000 (-3.6A) | 1.05A | 4xe0A-4bfrA:40.7 | 4xe0A-4bfrA:57.19 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4bfr | PHOSPHATIDYLINOSITOL4,5-BISPHOSPHATE3-KINASE CATALYTIC SSUBUNIT BETA ISOFORM (Mus musculus) |
PF00454(PI3_PI4_kinase)PF00613(PI3Ka)PF00792(PI3K_C2)PF00794(PI3K_rbd) | 6 | MET A 773PRO A 779TRP A 781ILE A 797TYR A 833ILE A 930 | J82 A2000 (-3.9A)J82 A2000 (-4.5A)NoneJ82 A2000 (-4.4A)J82 A2000 (-3.7A)J82 A2000 (-3.6A) | 0.90A | 4xe0A-4bfrA:40.7 | 4xe0A-4bfrA:57.19 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4bfr | PHOSPHATIDYLINOSITOL4,5-BISPHOSPHATE3-KINASE CATALYTIC SSUBUNIT BETA ISOFORM (Mus musculus) |
PF00454(PI3_PI4_kinase)PF00613(PI3Ka)PF00792(PI3K_C2)PF00794(PI3K_rbd) | 6 | PRO A 779TRP A 781ILE A 797ASP A 856THR A 853ASP A 931 | J82 A2000 (-4.5A)NoneJ82 A2000 (-4.4A)NoneNoneJ82 A2000 (-4.9A) | 1.40A | 4xe0A-4bfrA:40.7 | 4xe0A-4bfrA:57.19 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4bfr | PHOSPHATIDYLINOSITOL4,5-BISPHOSPHATE3-KINASE CATALYTIC SSUBUNIT BETA ISOFORM (Mus musculus) |
PF00454(PI3_PI4_kinase)PF00613(PI3Ka)PF00792(PI3K_C2)PF00794(PI3K_rbd) | 7 | PRO A 779TRP A 781ILE A 797ASP A 856THR A 853MET A 920ILE A 930 | J82 A2000 (-4.5A)NoneJ82 A2000 (-4.4A)NoneNoneJ82 A2000 (-3.6A)J82 A2000 (-3.6A) | 1.28A | 4xe0A-4bfrA:40.7 | 4xe0A-4bfrA:57.19 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4bfr | PHOSPHATIDYLINOSITOL4,5-BISPHOSPHATE3-KINASE CATALYTIC SSUBUNIT BETA ISOFORM (Mus musculus) |
PF00454(PI3_PI4_kinase)PF00613(PI3Ka)PF00792(PI3K_C2)PF00794(PI3K_rbd) | 7 | PRO A 779TRP A 781ILE A 797TYR A 833THR A 853MET A 920ILE A 930 | J82 A2000 (-4.5A)NoneJ82 A2000 (-4.4A)J82 A2000 (-3.7A)NoneJ82 A2000 (-3.6A)J82 A2000 (-3.6A) | 0.79A | 4xe0A-4bfrA:40.7 | 4xe0A-4bfrA:57.19 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4bfr | PHOSPHATIDYLINOSITOL4,5-BISPHOSPHATE3-KINASE CATALYTIC SSUBUNIT BETA ISOFORM (Mus musculus) |
PF00454(PI3_PI4_kinase)PF00613(PI3Ka)PF00792(PI3K_C2)PF00794(PI3K_rbd) | 7 | TRP A 781ILE A 797TYR A 833VAL A 848THR A 853MET A 920ILE A 930 | NoneJ82 A2000 (-4.4A)J82 A2000 (-3.7A)J82 A2000 (-3.8A)NoneJ82 A2000 (-3.6A)J82 A2000 (-3.6A) | 0.75A | 4xe0A-4bfrA:40.7 | 4xe0A-4bfrA:57.19 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4bfr | PHOSPHATIDYLINOSITOL4,5-BISPHOSPHATE3-KINASE CATALYTIC SSUBUNIT BETA ISOFORM (Mus musculus) |
PF00454(PI3_PI4_kinase)PF00613(PI3Ka)PF00792(PI3K_C2)PF00794(PI3K_rbd) | 5 | TYR A 833VAL A 847THR A 853MET A 920ILE A 930 | J82 A2000 (-3.7A)J82 A2000 (-3.7A)NoneJ82 A2000 (-3.6A)J82 A2000 (-3.6A) | 1.38A | 4xe0A-4bfrA:40.7 | 4xe0A-4bfrA:57.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4dpp | DIHYDRODIPICOLINATESYNTHASE 2,CHLOROPLASTIC (Arabidopsisthaliana) |
PF00701(DHDPS) | 5 | PRO A 269TYR A 87THR A 108ASN A 300ILE A 72 | None | 1.44A | 4xe0A-4dppA:undetectable | 4xe0A-4dppA:15.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4hnn | DIHYDRODIPICOLINATESYNTHASE (Vitis vinifera) |
PF00701(DHDPS) | 5 | PRO A 231TYR A 49THR A 70ASN A 262ILE A 34 | NoneNoneKPI A 184 ( 3.8A)NoneNone | 1.37A | 4xe0A-4hnnA:undetectable | 4xe0A-4hnnA:15.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4hw6 | HYPOTHETICALPROTEIN, IPT/TIGDOMAIN PROTEIN (Bacteroidesovatus) |
PF01833(TIG) | 5 | PRO A 289ILE A 274VAL A 219ASP A 179ASN A 181 | None | 1.39A | 4xe0A-4hw6A:undetectable | 4xe0A-4hw6A:16.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4jhm | MANDELATE RACEMASE /MUCONATE LACTONIZINGENZYME, C-TERMINALDOMAIN PROTEIN (Pseudovibriosp. JE062) |
PF02746(MR_MLE_N)PF13378(MR_MLE_C) | 5 | ILE A 64VAL A 38ASP A 106ASN A 87ILE A 71 | None | 1.23A | 4xe0A-4jhmA:undetectable | 4xe0A-4jhmA:16.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4kk7 | ESX-1 SECRETIONSYSTEM PROTEIN ECCB1 (Mycobacteriumtuberculosis) |
PF05108(T7SS_ESX1_EccB) | 5 | PRO A 449ILE A 130VAL A 104THR A 425ASN A 422 | None | 1.43A | 4xe0A-4kk7A:undetectable | 4xe0A-4kk7A:17.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4mzv | EPITHELIAL CELLADHESION MOLECULE (Homo sapiens) |
PF00086(Thyroglobulin_1) | 5 | ILE A 146ASP A 253THR A 141ASN A 120ILE A 209 | DMU A 301 (-4.6A)NoneNoneNoneNone | 0.96A | 4xe0A-4mzvA:undetectable | 4xe0A-4mzvA:14.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4nji | 7-CARBOXY-7-DEAZAGUANINE SYNTHASE (Burkholderiamultivorans) |
PF13394(Fer4_14) | 5 | MET A 95PRO A 94VAL A 71ASP A 104ILE A 113 | None | 1.42A | 4xe0A-4njiA:undetectable | 4xe0A-4njiA:13.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ox9 | 16S RRNA(ADENINE(1408)-N(1))-METHYLTRANSFERASE (Escherichiacoli) |
PF02390(Methyltransf_4) | 5 | ILE Y 68VAL Y 81ASP Y 55THR Y 33ILE Y 39 | NoneNoneSFG Y 301 (-2.8A)NoneNone | 1.38A | 4xe0A-4ox9Y:undetectable | 4xe0A-4ox9Y:14.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4tvc | DEXTRANSUCRASE (Leuconostocmesenteroides) |
PF02324(Glyco_hydro_70) | 5 | MET A2289TYR A2376THR A2277ASN A2278ILE A2318 | None | 1.35A | 4xe0A-4tvcA:2.3 | 4xe0A-4tvcA:20.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4xfw | ALPHA-CARBONICANHYDRASE (Helicobacterpylori) |
PF00194(Carb_anhydrase) | 5 | ILE A 239VAL A 203ASN A 121ILE A 54ASP A 234 | None | 1.44A | 4xe0A-4xfwA:undetectable | 4xe0A-4xfwA:11.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4xzw | ENDO-GLUCANASECHIMERA C10 (unculturedbacterium;Geobacillus sp.70PC53) |
PF00150(Cellulase) | 5 | PRO A 111ILE A 153TYR A 199VAL A 184THR A 229 | None | 1.41A | 4xe0A-4xzwA:undetectable | 4xe0A-4xzwA:15.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4ykn | PHOSPHATIDYLINOSITOL3-KINASE REGULATORYSUBUNITALPHA,PHOSPHATIDYLINOSITOL4,5-BISPHOSPHATE3-KINASE CATALYTICSUBUNIT ALPHAISOFORM FUSIONPROTEIN (Homo sapiens) |
PF00017(SH2)PF00454(PI3_PI4_kinase)PF00613(PI3Ka)PF00792(PI3K_C2)PF00794(PI3K_rbd)PF02192(PI3K_p85B)PF16454(PI3K_P85_iSH2) | 5 | ILE A1848VAL A1851THR A1856MET A1922ILE A1932 | 4EL A2101 (-3.9A)4EL A2101 (-4.0A)4EL A2101 ( 4.3A)4EL A2101 (-3.7A)4EL A2101 (-3.8A) | 1.19A | 4xe0A-4yknA:31.3 | 4xe0A-4yknA:32.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4ykn | PHOSPHATIDYLINOSITOL3-KINASE REGULATORYSUBUNITALPHA,PHOSPHATIDYLINOSITOL4,5-BISPHOSPHATE3-KINASE CATALYTICSUBUNIT ALPHAISOFORM FUSIONPROTEIN (Homo sapiens) |
PF00017(SH2)PF00454(PI3_PI4_kinase)PF00613(PI3Ka)PF00792(PI3K_C2)PF00794(PI3K_rbd)PF02192(PI3K_p85B)PF16454(PI3K_P85_iSH2) | 7 | MET A1772PRO A1778TYR A1836VAL A1851THR A1856MET A1922ILE A1932 | 4EL A2101 (-4.6A)4EL A2101 (-4.2A)4EL A2101 (-4.1A)4EL A2101 (-4.0A)4EL A2101 ( 4.3A)4EL A2101 (-3.7A)4EL A2101 (-3.8A) | 1.06A | 4xe0A-4yknA:31.3 | 4xe0A-4yknA:32.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4ykn | PHOSPHATIDYLINOSITOL3-KINASE REGULATORYSUBUNITALPHA,PHOSPHATIDYLINOSITOL4,5-BISPHOSPHATE3-KINASE CATALYTICSUBUNIT ALPHAISOFORM FUSIONPROTEIN (Homo sapiens) |
PF00017(SH2)PF00454(PI3_PI4_kinase)PF00613(PI3Ka)PF00792(PI3K_C2)PF00794(PI3K_rbd)PF02192(PI3K_p85B)PF16454(PI3K_P85_iSH2) | 8 | PRO A1778TRP A1780ILE A1800TYR A1836VAL A1851THR A1856MET A1922ILE A1932 | 4EL A2101 (-4.2A)None4EL A2101 ( 4.4A)4EL A2101 (-4.1A)4EL A2101 (-4.0A)4EL A2101 ( 4.3A)4EL A2101 (-3.7A)4EL A2101 (-3.8A) | 0.44A | 4xe0A-4yknA:31.3 | 4xe0A-4yknA:32.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4zoh | PUTATIVEOXIDOREDUCTASEFAD-BINDING SUBUNIT (Sulfurisphaeratokodaii) |
PF00941(FAD_binding_5)PF03450(CO_deh_flav_C) | 5 | MET B 126ILE B 164ASP B 118THR B 91ILE B 80 | NoneNoneFAD B 301 (-3.7A)NoneNone | 1.37A | 4xe0A-4zohB:2.0 | 4xe0A-4zohB:14.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4zr5 | NEPRILYSIN (Oryctolaguscuniculus) |
PF01431(Peptidase_M13)PF05649(Peptidase_M13_N) | 5 | PRO A 98ILE A 97TYR A 698ASN A 72ASP A 108 | NoneNoneNoneNoneRDF A 802 (-3.7A) | 1.35A | 4xe0A-4zr5A:3.1 | 4xe0A-4zr5A:21.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5c4g | PHOSPHATIDYLINOSITOL4-KINASE BETA (Homo sapiens) |
PF00454(PI3_PI4_kinase) | 5 | PRO E 381ILE E 547TYR E 583VAL E 598ILE E 673 | BQR E 803 ( 4.7A)BQR E 803 ( 4.7A)BQR E 803 ( 3.0A)BQR E 803 (-3.8A)BQR E 803 ( 3.9A) | 0.63A | 4xe0A-5c4gE:15.6 | 4xe0A-5c4gE:21.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5fq6 | PUTATIVE LIPOPROTEIN (Bacteroidesthetaiotaomicron) |
PF12771(SusD-like_2) | 5 | TRP A 392TYR A 252VAL A 255ASP A 263THR A 261 | None | 1.50A | 4xe0A-5fq6A:undetectable | 4xe0A-5fq6A:18.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5gy0 | GLUCANASE (Ruminiclostridiumthermocellum) |
PF00759(Glyco_hydro_9)PF00942(CBM_3) | 5 | VAL A 525ASP A 514ASN A 595MET A 513ILE A 582 | NoneNone CA A 702 (-2.9A)NoneNone | 1.47A | 4xe0A-5gy0A:undetectable | 4xe0A-5gy0A:21.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ip7 | DNA-DIRECTED RNAPOLYMERASES I, II,AND III SUBUNITRPABC1 (Saccharomycescerevisiae) |
PF01191(RNA_pol_Rpb5_C)PF03871(RNA_pol_Rpb5_N) | 5 | PRO E 151ILE E 198VAL E 195ILE E 178ASP E 182 | None | 1.49A | 4xe0A-5ip7E:undetectable | 4xe0A-5ip7E:12.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5j7x | DIMETHYLANILINEMONOOXYGENASE,PUTATIVE (Aspergillusflavus) |
PF00743(FMO-like) | 5 | PRO A 435ILE A 451TYR A 71ASN A 54ILE A 25 | NoneNoneNoneFAD A 601 (-3.5A)None | 1.18A | 4xe0A-5j7xA:undetectable | 4xe0A-5j7xA:19.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5m0y | CELLULOSOMEANCHORING PROTEINCOHESIN REGIONIG DOMAIN PROTEINGROUP 2 DOMAINPROTEIN (Ruminiclostridiumthermocellum;Ruminiclostridiumthermocellum) |
PF00963(Cohesin)no annotation | 5 | PRO A 79ILE A 132TYR A 57VAL A 56ASN B 158 | NoneNoneNoneNoneEDO A 203 ( 4.8A) | 1.48A | 4xe0A-5m0yA:undetectable | 4xe0A-5m0yA:12.10 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5m6u | PHOSPHATIDYLINOSITOL4,5-BISPHOSPHATE3-KINASE CATALYTICSUBUNIT DELTAISOFORM (Homo sapiens) |
PF00454(PI3_PI4_kinase)PF00613(PI3Ka)PF00792(PI3K_C2)PF00794(PI3K_rbd)PF02192(PI3K_p85B) | 9 | MET A 752PRO A 758TRP A 760TYR A 813VAL A 828ASP A 832THR A 833MET A 900ILE A 910 | 7KA A1101 ( 4.5A)7KA A1101 (-4.3A)None7KA A1101 (-3.5A)7KA A1101 (-4.1A)7KA A1101 (-3.7A)7KA A1101 ( 4.4A)7KA A1101 (-3.6A)7KA A1101 (-3.7A) | 0.36A | 4xe0A-5m6uA:50.1 | 4xe0A-5m6uA:94.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5nci | LEUCINE HYDROXYLASE (Streptomycesmuensis) |
PF05721(PhyH) | 5 | TRP A 116TYR A 228VAL A 128ASN A 97ILE A 226 | LEU A 303 (-3.4A)NoneNoneAKG A 302 (-3.3A)None | 1.24A | 4xe0A-5nciA:undetectable | 4xe0A-5nciA:14.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5osn | CAPSID PROTEIN (Enterovirus E) |
PF00073(Rhv) | 5 | MET C 94PRO C 93ILE C 55ASP C 114ILE C 195 | NoneNoneNone K C 301 (-4.0A)None | 1.40A | 4xe0A-5osnC:undetectable | 4xe0A-5osnC:12.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5t6o | POLY-BETA-HYDROXYBUTERATE POLYMERASE (Cupriavidusnecator) |
PF07167(PhaC_N) | 5 | ILE A 324TYR A 440THR A 430ASN A 279ILE A 247 | None | 1.42A | 4xe0A-5t6oA:undetectable | 4xe0A-5t6oA:17.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ui3 | DIHYDRODIPICOLINATESYNTHASE (Chlamydomonasreinhardtii) |
no annotation | 5 | PRO D 229TYR D 47THR D 68ASN D 260ILE D 32 | NoneNoneAKG D 401 (-3.6A)AKG D 401 (-3.8A)None | 1.32A | 4xe0A-5ui3D:undetectable | 4xe0A-5ui3D:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5xgj | PHOSPHATIDYLINOSITOL4,5-BISPHOSPHATE3-KINASE CATALYTICSUBUNIT ALPHAISOFORM (Homo sapiens) |
no annotation | 5 | ILE A 848VAL A 851THR A 856MET A 922ILE A 932 | 84X A1101 ( 4.3A)84X A1101 (-3.7A)None84X A1101 ( 4.3A)84X A1101 ( 3.8A) | 1.13A | 4xe0A-5xgjA:41.1 | 4xe0A-5xgjA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5xgj | PHOSPHATIDYLINOSITOL4,5-BISPHOSPHATE3-KINASE CATALYTICSUBUNIT ALPHAISOFORM (Homo sapiens) |
no annotation | 5 | PRO A 778TRP A 780ILE A 800TYR A 836ILE A 932 | 84X A1101 (-4.3A)NoneNone84X A1101 (-4.4A)84X A1101 ( 3.8A) | 0.81A | 4xe0A-5xgjA:41.1 | 4xe0A-5xgjA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5xgj | PHOSPHATIDYLINOSITOL4,5-BISPHOSPHATE3-KINASE CATALYTICSUBUNIT ALPHAISOFORM (Homo sapiens) |
no annotation | 7 | TRP A 780ILE A 800TYR A 836VAL A 851THR A 856MET A 922ILE A 932 | NoneNone84X A1101 (-4.4A)84X A1101 (-3.7A)None84X A1101 ( 4.3A)84X A1101 ( 3.8A) | 0.63A | 4xe0A-5xgjA:41.1 | 4xe0A-5xgjA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5y3r | DNA-DEPENDENTPROTEIN KINASECATALYTIC SUBUNIT (Homo sapiens) |
PF00454(PI3_PI4_kinase)PF02259(FAT)PF02260(FATC)PF08163(NUC194) | 5 | PRO C3735ASP C3814THR C3811MET C3929ASP C3941 | None | 1.42A | 4xe0A-5y3rC:undetectable | 4xe0A-5y3rC:12.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5y3r | DNA-DEPENDENTPROTEIN KINASECATALYTIC SUBUNIT (Homo sapiens) |
PF00454(PI3_PI4_kinase)PF02259(FAT)PF02260(FATC)PF08163(NUC194) | 5 | PRO C3735ILE C3803THR C3809ILE C3940ASP C3941 | None | 1.41A | 4xe0A-5y3rC:undetectable | 4xe0A-5y3rC:12.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6emk | SERINE/THREONINE-PROTEIN KINASE TOR2 (Saccharomycescerevisiae) |
no annotation | 5 | TYR A2164ASP A2183THR A2184MET A2284ILE A2295 | None | 1.45A | 4xe0A-6emkA:undetectable | 4xe0A-6emkA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6gl3 | - (-) |
no annotation | 5 | PRO A 396ILE A 562TYR A 598VAL A 613ILE A 688 | NoneNoneEMW A 801 (-3.5A)EMW A 801 (-4.1A)EMW A 801 (-3.5A) | 0.57A | 4xe0A-6gl3A:undetectable | 4xe0A-6gl3A:undetectable |